You are here

Wegovy

UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy

Yahoo/Reuters

Fri, 12/13/24 - 11:43 am

Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial

BioPharma Dive

Wed, 12/4/24 - 11:02 am

clinical trials

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms

Pharma Live

Tue, 12/3/24 - 11:36 am

Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

MSN

Wed, 11/27/24 - 09:57 pm

Biden proposes Medicare and Medicaid cover weight loss drugs

Axios

Tue, 11/26/24 - 09:51 am

Novo’s Wegovy Launched in China at a Fraction of US Price

BioSpace

Mon, 11/18/24 - 11:28 am

Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight

Xtalks

Fri, 11/15/24 - 11:27 am

FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels

Beckers Hospital Review

Wed, 11/6/24 - 08:01 pm

Novo Nordisk Q3 earnings: Wegovy sales soar 79% year-over-year

Yahoo Finance

Wed, 11/6/24 - 11:44 am

States slow to cover GLP-1s for weight loss

Axios

Wed, 11/6/24 - 11:37 am

Wegovy reduces all-cause admissions: 3 study findings

Beckers Hospital Review

Mon, 11/4/24 - 11:19 am

hospital admissions

clinical trials

Novo takes big step toward ending Ozempic, Wegovy shortages

BioPharma Dive

Wed, 10/30/24 - 08:48 pm

Weight-loss drugs didn't curb health costs within two years

Reuters

Thu, 10/24/24 - 11:11 am

FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage

Pharma Voice

Mon, 10/21/24 - 09:37 am

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

BioPharma Dive

Fri, 10/11/24 - 11:10 am

Skye Bioscience

Novo’s GLP-1 Wegovy could improve heart health for millions more than previously thought, AI study finds

Pharma Voice

Mon, 10/7/24 - 11:23 am

cardiovascular disease

artificial intelligence

Dandelion Health

Novo Nordisk has mitigation plans to minimize disruption from port strikes

Reuters

Thu, 10/3/24 - 11:47 am

Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings

Forbes

Wed, 10/2/24 - 11:20 am

Inside the GLP-1 'price war'

Beckers Hospital Review

Tue, 09/24/24 - 11:52 am

U.S. Senator Sanders says pharmacy middlemen commit to expanding weight-loss drug coverage if prices cut

Reuters

Tue, 09/24/24 - 11:40 am

Pages